Magnetic resonance imaging of prostatic cancer: Does detection vary between high and low gleason score tumors?

Prostate

Volumn 43, Issue 1, 2000, Pages 43-48

  Ikonen, Saana ^a   Kärkkäinen, Päivi ^a   Kivisaari, Leena ^a   Salo, Jaakko O ^a   Taari, Kimmo ^a   Vehmas, Tapio ^b   Tervahartiala, Pekka ^a   Rannikko, Sakari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Gleason score; Magnetic resonance imaging; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; TUMOR VOLUME;

EID: 0342804389     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000401)43:1<43::AID-PROS6>3.0.CO;2-S     Document Type: Article

References (21)

1. Gleason DF, Mellinger GT, Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
2. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626-631.
3. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993;71:3582-3593.
4. Bostwick DG, Qian J, Bergstralh E, Dundore P, Dugan J, Myers RP, Oesterling JE. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996;155:1361-1367.
5. Carrol LC, Sommer FG, McNeal JE, Stamey TA. The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation. Radiology 1987;163:521-525.
6. Carter HB, Brem RF, Tempany CM, Yang A, Epstein JI, Walsh PC, Zerhouni EA. Nonpalpable prostate cancer: detection with MR imaging. Radiology 1991;178:523-525.
7. Ellis JH, Tempany C, Sarin MS, Gatsonis C, Rifkin MD, McNeil BJ. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR 1994;162:865-872.
8. Ikonen S, Kärkkäinen P, Kivisaari L, Salo JO, Taari K, Vehmas T, Tervahartiala P, Rannikko S. Magnetic resonance imaging of clinically localized prostatic cancer. J Urol 1998;159:915-919.
9. Quinn SF, Franzini DA, Demlow TA, Rosencrantz DR, Kim J, Hanna RM, Szumowski J. MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. Radiology 1994;190:323-327.
10. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll PR. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 1994; 193:703-709.
11. Schiebler ML, Schnall MD, Pollack HM, Lenkinski RE, Tomaszewski JE, Wein AJ, Whittington R, Rauschning W, Kressel HY. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993;189:339-352.
12. Hoff C. Chi-square trend analysis in antigen sharing studies. Tissue Antigens 1985;26:212-213.
13. Wulff HR, Schlichting P. Manual for Medstat. Alberstslund, Denmark: Astra-Group A/S; 1991. p 116-117.
14. Rohlf FJ, Sokal RR. Statistical tables. New York: W.H. Freeman and Co.; 1995. p 28.
15. Jager GJ, Ruijter ET, Van de Kaa CA, de la Rosette JJMCH, Oosterhof GON, Thornbury JR, Barentsz JO. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR 1996;166:845-852.
16. Oefelein MG, Grayhack JT, McVary KT. Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate. Cancer 1995;76:2535-2542.
17. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110-114.
18. Babaian RJ, Troncoso P, Steelhammer LC, Lloreta-Trull J, Ramirez EI. Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. J Urol 1995;154:1808-1812.
19. Perrotti M, Kaufman RP, Jennings TA, Thaler HT, Soloway SM, Rifkin MD, Fisher HAG. Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol 1996;156:106-109.
20. D'Amico AV, Whittington R, Schnall M, Malkowicz B, Tomaszevski JE, Schultz D, Wein A. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer. Cancer 1995;75:2368-2372.
21. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszevski JE, Wein A. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol 1995;154:131-138.